Emc IP Holding Company LLC

Lenovo (beijing) Limited

Shandong University

Institute of Pharmacology and Toxicology Academy of Military Medical Science P.l.a. China

Sciwind Biosciences Co., Ltd.

Institute of Pharmacology and Toxicology Academy of Military Science P.l.a. China

The First Medical Center Chinese Pla General Hospital

Institute of Pharmacology and Toxicology Academy of Military Medical Sciences Pla China

Rui Song

Jin Li

Hui Zhu

Liuhong Yun

Rifang Yang

Rusheng Zhao

Ning Wu

Ruibin Su

Feng Li

Jing Feng

Chenxi Hu

Lihai Zhang

Ye Peng

Shuwei Zhang

Gongzi Zhang

Zheng Xu

Hai Pan

Fuxin Du

Yanqiang Lei

Wanjun Guo

Disclosed is an in-vivo micro-robot for nerve stretching, comprising a channel, and a movable part and a fixed part located at the channel. The movable part is disposed to be movable along the channel, the movable part sleeves the fixed part and is used for driving the fixed part to move along the channel, and the fixed part is connected to a nerve to be stretched. The in-vivo micro-robot is embedded into a patient's body through surgery, so that the extension of the nerve is accelerated and is regular and quantitative, thereby effectively solving the problems of small probability of nerve self-repair and long recovery period in traditional nerve bridging surgery.

In-vivo micro-robot for nerve stretching

A heat dissipation fan includes: a body including a fan air inlet surface, a central shaft driving surface located inside the fan air inlet surface, and a plurality of protrusion structures configured at spacings in a circumference direction of the central shaft driving surface; and fan blades including first fan blades connected between the central shaft driving surface and the fan air inlet surface, and second fan blades connected between the protrusion structure and the fan air inlet surface. A fan air inlet angle is formed between each fan blade and the central shaft driving surface, and the plurality of protrusion structures are configured to vary the fan air inlet angle to control a flow field of an airflow entering the fan air inlet angle.

Heat dissipation fan

Embodiments of the present disclosure provide a method, an electronic device, and a computer program product for managing an operating system. The method includes receiving a version upgrade request for the system. The method further includes using a target system image to upgrade the system from a first version to a second version corresponding to the target system image. The method further includes storing, in response to determining that the system operates normally within a first time period, the target system image to a first storage device for the system without updating a historical system image stored in a second storage device for the system, wherein the historical system image corresponds to the first version. In this way, by storing image files of different versions for selectively resetting the operating system in case of a failure, stability of the system after an upgrade is improved.

Method, electronic device, and computer program product for managing operating system

Provided are a GLP-1(7-37) polypeptide analogue, a fatty acid-modified derivative of the analogue, and a medicament comprising the derivative. Further, also provided are a preparation method of the derivative, and use of the same in the preparation of a medicament.

Acylated GLP-1 derivative

The present invention relates to a novel piperazine derivative represented by Formula I having an activity for regulating dopamine D3 receptor, stereoisomers thereof, pharmaceutically acceptable salts or solvates, and a pharmaceutical composition comprising the compound, a process for preparing the same, and use thereof in the prevention or treatment of a disease associated with central nervous system dysfunction, such as Parkinson's disease, schizophrenia, drug addiction and relapse, as well as kidney protection and immunoregulation, or as a tool for researching D3R function or diseases associated with D3R dysfunction. 

Dopamine D3 receptor ligands and preparation and medical uses of the same

The present invention relates to a novel piperazine derivative represented by Formula I having an activity for regulating dopamine D3 receptor, stereoisomers thereof, pharmaceutically acceptable salts or solvates, and a pharmaceutical composition comprising the compound, a process for preparing the same, and use thereof in the prevention or treatment of a disease associated with central nervous system dysfunction, such as Parkinson's disease, schizophrenia, drug addiction and relapse, as well as kidney protection and immunoregulation, or as a tool for researching D3R function or diseases associated with D3R dysfunction.

Growing community of inventors

Beijing, China

Rui Song